Penny Stocks Worth Watching - January 9th

Key Points

• MarketBeat flags three penny stocks to watch: Offerpad Solutions (OPAD) — a tech-enabled iBuying residential real-estate platform; Sidus Space (SIDU) — a space-as-a-service company building and launching satellites and providing geospatial data; and Aquestive Therapeutics (AQST) — a pharmaceutical company marketing oral film therapies.
• These companies were highlighted because they posted the highest dollar trading volume among penny stocks over the past several days, indicating elevated market activity and investor interest.
• Penny stocks are generally shares trading under $5 with low liquidity, wide bid-ask spreads and high volatility, making them speculative and higher-risk investments that are more susceptible to fraud or price manipulation.

Offerpad Solutions, Sidus Space, and Aquestive Therapeutics are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small public companies—commonly defined by the SEC as trading for less than $5 per share—often listed on over-the-counter markets or smaller exchanges. They typically have low liquidity, wide bid-ask spreads and high volatility, making them speculative and higher-risk investments that are more susceptible to fraud or price manipulation. These companies had the highest dollar trading volume of any Penny stocks within the last several days.

Offerpad Solutions (OPAD)

Offerpad Solutions Inc., together with its subsidiaries, provides technology-enabled solutions for residential real estate market in the United States. It operates iBuying, a real estate solutions platform for on-demand customer that provides home buyers the opportunity to browse and tour homes online.

Read Our Latest Research Report on OPAD

Sidus Space (SIDU)

Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.

Read Our Latest Research Report on SIDU

Aquestive Therapeutics (AQST)

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder.

Read Our Latest Research Report on AQST

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.